JBS (NYSE:JBS) Posts Quarterly Earnings Results, Misses Expectations By $0.10 EPS

JBS (NYSE:JBS) announced its quarterly earnings data on Monday. The company reported $0.16 EPS for the quarter, missing the consensus estimate of $0.26 by ($0.10), Zacks reports. JBS had a return on equity of 7.61% and a net margin of 0.76%. The company had revenue of $22.74 billion during the quarter. During the same quarter last year, the company posted $0.54 earnings per share. The business’s revenue for the quarter was up .6% on a year-over-year basis.

JBS Price Performance

JBS stock traded down $0.26 during mid-day trading on Wednesday, hitting $12.14. 1,893,028 shares of the stock were exchanged, compared to its average volume of 5,850,284. The company has a debt-to-equity ratio of 2.51, a current ratio of 1.53 and a quick ratio of 0.77. The business has a fifty day moving average price of $12.38 and a 200 day moving average price of $14.01. JBS has a 12 month low of $10.61 and a 12 month high of $18.65. The stock has a market capitalization of $9.43 billion, a price-to-earnings ratio of 18.72, a PEG ratio of 3.46 and a beta of -1.55.

Latest JBS News

Here’s some of the latest news about JBS:

• Positive Sentiment: JBS reported a recovery in U.S. beef results, offering a positive counterpoint to weakness elsewhere in the business. Reuters article
• Neutral Sentiment: The company agreed to buy Brazilian consumer-products maker Flora for $542 million, adding beauty and personal-care products to its portfolio. The deal expands JBS’s consumer-products platform, though its near-term financial impact is unclear. JBS acquisition announcement
• Negative Sentiment: China’s beef import quotas are weighing on results, while pork remains under pressure. Investors may view these headwinds as limiting the benefit of the U.S. beef improvement and contributing to the stock’s decline. Yahoo Finance article

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Weiss Ratings raised JBS from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, October 30th. JPMorgan Chase & Co. reduced their price objective on shares of JBS from $18.00 to $17.50 and set an “overweight” rating for the company in a research note on Thursday, October 22nd. Stephens dropped their target price on JBS from $18.00 to $17.00 and set an “overweight” rating on the stock in a research report on Monday, August 17th. Barclays cut their price target on JBS from $21.00 to $20.00 and set an “overweight” rating for the company in a report on Thursday, July 16th. Finally, Wall Street Zen cut JBS from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, JBS presently has an average rating of “Moderate Buy” and an average price target of $18.10.

Insider Transactions at JBS

In other news, CFO Guilherme Cavalcanti sold 183,501 shares of the business’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $13.85, for a total value of $2,541,488.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

About JBS

JBS S.A. is a global food company focused on processing beef, pork, poultry and lamb. Its products include fresh and frozen meat, prepared and packaged foods, and value-added food products sold under brands such as Swift, Pilgrim’s and Seara. The company also produces ingredients and other products from animal byproducts, including leather and collagen. Founded in 1953 in Anápolis, Brazil, JBS has grown into an international business with operations across the Americas, Europe, Australia and other markets.